Potential Therapeutics Against COVID-19 In Pediatrics

Sailender14 Sep, 2021Health

Treatment of COVID-19 pediatric patients entails supportive and symptomatic management. Unfortunately, no RCTs have included pediatric patients, to date. The available evidence is obtained from adult studies. Remdesivir is the only USFDA-approved anti-COVID-19 medication indicated in the majority of symptomatic patients with moderate to severe disease. According to the USFDA, remdesivir is recommended in hospitalized children aged 12 years and above, and weighing at least 40 kg.